Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
Sinovac Biotech Total Liabilities (Quarterly): 1.390B for June 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| China Pharma Holding Inc | 6.937M |
| CASI Pharmaceuticals Inc | 49.77M |
| Zai Lab Ltd | 317.68M |
| Adagene Inc | 44.19M |
| LakeShore Biopharma Co Ltd | 118.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.90B |
| Shareholders Equity (Quarterly) | 8.649B |
| Debt to Equity Ratio | 0.0358 |
| Current Ratio | 11.39 |
| Net Debt Paydown Yield | -21.04% |